The DOI matches its Crossref record.
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Abstract
Murine IL-10 (cytokine synthesis inhibitory factor) inhibits cytokine production by Th1 cell clones when they are activated under conditions requiring the presence of APC. By preincubating APC with IL-10, we demonstrate that IL-10 acts principally on APC to inhibit IFN-gamma production by Th1 clones. Moreover, IL-10 is not active when Th1 cells are stimulated with glutaraldehyde-fixed APC, which also indicates that its action involves regulation of APC function. Furthermore, IL-10 inhibits cytokine synthesis by Th1 cells stimulated with the super-antigen Staphylococcus enterotoxin B, which does not appear to require processing. Flow microfluorimetry purified splenic or peritoneal B cells and macrophages, and B cell and macrophage cell lines can present Ag to Th1 clones. However, IL-10 acts only on sorted macrophages and the macrophage cell line to suppress IFN-gamma production by Th1 clones. IL-10 does not show this effect when B cells are used as APC. In contrast, IL-10 does not impair the ability of APC to stimulate cytokine production by Th2 cells. IL-10 does not decrease IFN-gamma-induced I-Ad levels on a macrophage cell line. Inasmuch as IL-10 also inhibits IL-2-induced IFN-gamma production by Th1 cells in an Ag-free system requiring only the presence of accessory cells, these data suggest that IL-10 may inhibit macrophage accessory cell function which is independent of TCR-class II MHC interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Items 101–165 of 165
Nelson, D. R., Lauwers, G. Y., Lau, J. Y. N., & Davis, G. L. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70134-x · Cited by 349
Biological properties of interleukin 10
Howard, M., O'Garra, A., Ishida, H., de Waal Malefyt, R., & De Vries, J. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918147 · Cited by 348
Self-citationShreedhar, V., Giese, T., Sung, V. W., & Ullrich, S. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3783 · Cited by 345
Differential Regulation of Murine T Lymphocyte Subsets
Fitch, F. W., McKisic, M. D., Lancki, D. W., & Gajewski, T. F. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.000333 · Cited by 341
Levy, Y., & Brouet, J. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116977 · Cited by 340
Silver nanoparticles—the real “silver bullet” in clinical medicine?
Wong, K. K. Y., & Liu, X. (2010) · MedChemComm · doi:10.1039/c0md00069h · Cited by 332
Liew, F. Y., & O'Donnell, C. A. (1993) · Advances in Parasitology · doi:10.1016/s0065-308x(08)60208-0 · Cited by 332
Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivo
Powrie, F., Menon, S., & Coffman, R. L. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230926 · Cited by 328
Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type I
Sutterwala, F. S., Noel, G. J., Salgame, P., & Mosser, D. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.217 · Cited by 327
Immune defects observed in patients with primary malignant brain tumors
Dix, A. R., Brooks, W. H., Roszman, T. L., & Morford, L. A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00203-9 · Cited by 323
Bacteria-triggered CD4+ T Regulatory Cells Suppress Helicobacter hepaticus–induced Colitis
Kullberg, M. C., Jankovic, D., Gorelick, P. L., Caspar, P., Letterio, J. J., Cheever, A. W., & Sher, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020556 · Cited by 322
Natural Immunity: A T‐Cell‐Independent Pathway of Macrophage Activation, Defined in the scid Mouse
Bancroft, G. J., Schreiber, R. D., & Unanue, E. R. (1991) · Immunological Reviews · doi:10.1111/j.1600-065x.1991.tb00613.x · Cited by 319
Huber, V. C., Lynch, J. M., Bucher, D. J., Le, J., & Metzger, D. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7381 · Cited by 319
Hanna, N., Hanna, I., Hleb, M., Wagner, E., Dougherty, J., Balkundi, D., Padbury, J., & Sharma, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5721 · Cited by 313
de Waal Malefyt, R., Hans, Y., Roncarolo, M.-G., Spits, H., & de Vries, J. E. (1992) · Current Opinion in Immunology · doi:10.1016/0952-7915(92)90082-p · Cited by 312
Theiler's Virus Infection: a Model for Multiple Sclerosis
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., & Platsoucas, C. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.174-207.2004 · Cited by 308
Matsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G., & Kiessling, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2371 · Cited by 306
Interleukin 10 Receptor Signaling
Shouval, D. S., Ouahed, J., Biswas, A., Goettel, J. A., Horwitz, B. H., Klein, C., Muise, A. M., & Snapper, S. B. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00005-5 · Cited by 304
Velupillai, P., & Harn, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.18 · Cited by 299
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells
Görgün, G., Holderried, T. A. W., Zahrieh, D., Neuberg, D., & Gribben, J. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24176 · Cited by 298
Immunopathogenesis of recurrent vulvovaginal candidiasis
Fidel, P. L., & Sobel, J. D. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.3.335 · Cited by 298
Assenmacher, M., Schmitz, J., & Radbruch, A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240513 · Cited by 296
New insights into the molecular mechanism of interleukin-10-mediated immunosuppression
Grütz, G. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904484 · Cited by 296
Wogensen, L., Lee, M. S., & Sarvetnick, N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1379 · Cited by 294
Inflammation and preterm birth
Cappelletti, M., Della Bella, S., Ferrazzi, E., Mavilio, D., & Divanovic, S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0615-272rr · Cited by 293
King, C. L., Mahanty, S., Kumaraswami, V, Abrams, J. S., Regunathan, J., Jayaraman, K., Ottesen, E. A., & Nutman, T. B. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116752 · Cited by 292
Tacchini-Cottier, F., Zweifel, C., Belkaid, Y., Mukankundiye, C., Vasei, M., Launois, P., Milon, G., & Louis, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2628 · Cited by 291
Human interleukin-10 can directly inhibit T-cell growth
Taga, K., Mostowski, H., & Tosato, G. (1993) · Blood · doi:10.1182/blood.v81.11.2964.2964 · Cited by 291
The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain
Donnelly, R. P., Sheikh, F., Kotenko, S. V., & Dickensheets, H. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0204117 · Cited by 289
“Shortly thereafter, it was determined that the ability of IL-10 to inhibit cytokine production by T cells was indirectly mediated via its inhibitory effects on antigen-presenting cells (APC) such as monocytes, macrophages, and dendritic cells (DC) [6, 7].”
BackgroundBour, H., Peyron, E., Gaucherand, M., Garrigue, J., Desvignes, C., Kaiserlian, D., Revillard, J., & Nicolas, J. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251103 · Cited by 286
Cacciarelli, T. V., Martinez, O. M., Gish, R. G., Villanueva, J. C., & Krams, S. M. (1996) · Hepatology · doi:10.1002/hep.510240102 · Cited by 284
The interleukin‐12 subunit p40 specifically inhibits effects of the interleukin‐12 heterodimer
Mattner, F., Fischer, S., Guckes, S., Jin, S., Kaulen, H., Schmitt, E., Rüde, E., & Germann, T. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230923 · Cited by 279
Rapid development of colitis in NSAID-treated IL-10–deficient mice
Berg, D. J., Zhang, J., Weinstock, J. V., Ismail, H. F., Earle, K. A., Alila, H., Pamukcu, R., Moore, S., & Lynch, R. G. (2002) · Gastroenterology · doi:10.1053/gast.2002.1231527 · Cited by 279
In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice
Turner, J., Gonzalez-Juarrero, M., Ellis, D. L., Basaraba, R. J., Kipnis, A., Orme, I. M., & Cooper, A. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6343 · Cited by 277
Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development
Wang, H. J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i11.1304 · Cited by 277
IL-10 mediates susceptibility toLeishmania donovani infection
Murphy, M. L., Wille, U., Villegas, E. N., Hunter, C. A., & Farrell, J. P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2848::aid-immu2848>3.0.co;2-t · Cited by 275
Finkelman, F. D., Madden, K. B., Cheever, A. W., Katona, I. M., Morris, S. C., Gately, M. K., Hubbard, B. R., Gause, W. C., & Urban, J. F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1563 · Cited by 273
Endharti, A. T., Rifa’, M., Shi, Z., Fukuoka, Y., Nakahara, Y., Kawamoto, Y., Takeda, K., Isobe, K.-I., & Suzuki, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7093 · Cited by 271
Altered Immune Responses in Interleukin 10 Transgenic Mice
Hagenbaugh, A., Sharma, S., Dubinett, S. M., Wei, S. H.-Y., Aranda, R., Cheroutre, H., Fowell, D. J., Binder, S., Tsao, B., Locksley, R. M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2101 · Cited by 269
Self-citationCytokine signaling-regulation of the immune response in normal and critically ill states
Oberholzer, A., Oberholzer, C., & Moldawer, L. L. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004001-00002 · Cited by 267
Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators
Renauld, J.-C. (2003) · Nature Reviews Immunology · doi:10.1038/nri1153 · Cited by 265
Xue, L., Gyles, S. L., Wettey, F. R., Gazi, L., Townsend, E., Hunter, M. G., & Pettipher, R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6531 · Cited by 261
Does the failure to acquire helminthic parasites predispose to Crohn's disease?
Elliott, D. E., Urban, J. F., Argo, C. K., & Weinstock, J. V. (2000) · The FASEB Journal · doi:10.1096/fj.99-0885hyp · Cited by 260
Cytokines and Immune Response in the Tumor Microenvironment
Mocellin, S., Wang, E., & Marincola, F. M. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200109000-00002 · Cited by 259
Peña-Romero, A. C., & Orenes-Piñero, E. (2022) · Cancers · doi:10.3390/cancers14071681 · Cited by 257
The Effect of Inflammatory Cytokines in Alcoholic Liver Disease
Kawaratani, H., Tsujimoto, T., Douhara, A., Takaya, H., Moriya, K., Namisaki, T., Noguchi, R., Yoshiji, H., Fujimoto, M., & Fukui, H. (2013) · Mediators of Inflammation · doi:10.1155/2013/495156 · Cited by 256
Meyer, U., Murray, P. J., Urwyler, A., Yee, B. K., Schedlowski, M., & Feldon, J. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002042 · Cited by 252
Zhu, L. X., Sharma, S., Stolina, M., Gardner, B., Roth, M. D., Tashkin, D. P., & Dubinett, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.373 · Cited by 252
Jones, C. A., Cayabyab, R. G., Kwong, K. Y. C., Stotts, C., Wong, B., Hamdan, H., Minoo, P., & Delemos, R. A. (1996) · Pediatric Research · doi:10.1203/00006450-199606000-00007 · Cited by 252
VIALLARD, J. F., PELLEGRIN, J. L., RANCHIN, V, SCHAEVERBEKE, T., DEHAIS, J., LONGY-BOURSIER, M., RAGNAUD, J. M., LENG, B., & MOREAU, J. F. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00766.x · Cited by 247
Katiyar, S. K., Challa, A., McCormick, T. S., Cooper, K. D., & Mukhtar, H. (1999) · Carcinogenesis · doi:10.1093/carcin/20.11.2117 · Cited by 193
Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist
Lin, C., & Hünig, T. (2003) · European Journal of Immunology · doi:10.1002/eji.200323570 · Cited by 184
Interleukin‐10 modulates susceptibility in experimental cerebral malaria
KOSSODO, S., MONSO, C., JUILLARD, P., VELU, T., GOLDMAN, M., & GRAU, G. E. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00290.x · Cited by 180
Maseda, D., Candando, K. M., Smith, S. H., Kalampokis, I., Weaver, C. T., Plevy, S. E., Poe, J. C., & Tedder, T. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300649 · Cited by 144
“T cells, B cells, monocytes, macrophages, mast cells, and eosinophils can all secrete IL-10 that suppresses inflammatory cytokine production, Th1/Th2 polarization, and Ag presentation (5, 13, 14).”
BackgroundMouse models of ageing and their relevance to disease
Kõks, S., Dogan, S., Tuna, B. G., González-Navarro, H., Potter, P., & Vandenbroucke, R. E. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.10.001 · Cited by 125
“Interleukin-10 (IL-10) is a cytokine with anti-inflammatory ctivities via amongst others suppression of macrophage activaion and inhibition of the production of inflammatory cytokines roduced by Th1 cells (Fiorentino et al., 1991a, 1991b).”
BackgroundMohamed, S. G.-K., Sugiyama, E., Shinoda, K., Taki, H., Hounoki, H., Abdel-Aziz, H. O., Maruyama, M., Kobayashi, M., Ogawa, H., & Miyahara, T. (2007) · Bone · doi:10.1016/j.bone.2007.05.016 · Cited by 120
Kubera, M., Maes, M., Holan, V., Basta-Kaim, A., Roman, A., & Shani, J. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00182-8 · Cited by 103
Ko, K. S., Lee, M., Koh, J. J., & Kim, S. W. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0459 · Cited by 97
Jyonouchi, H., Zhang, L., & Tomita, Y. (1993) · Nutrition and Cancer · doi:10.1080/01635589309514258 · Cited by 83
Im, E., Riegler, F. M., Pothoulakis, C., & Rhee, S. H. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00120.2012 · Cited by 79
IL‐10 Production by CD5 B Cells
O'GARRA, A., & HOWARD, M. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24615.x · Cited by 74
Self-citationCHADBAN, TESCH, FOTI, LAN, ATKINS, & NIKOLIC‐PATERSON (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00487.x · Cited by 44
Strle, K., McCusker, R. H., Tran, L., King, A., Johnson, R. W., Freund, G. G., Dantzer, R., & Kelley, K. W. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.05.003 · Cited by 43
Strle, K., McCusker, R. H., Johnson, R. W., Zunich, S. M., Dantzer, R., & Kelley, K. W. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00662.2007 · Cited by 32
Picroside II Protects Rat Lung and A549 Cell Against LPS-Induced Inflammation by the NF-κB Pathway
Shen, B., Zhao, C., Chen, C., Li, Z., Li, Y., Tian, Y., & Feng, H. (2017) · Inflammation · doi:10.1007/s10753-017-0519-3 · Cited by 31
Metadata
- Authors
- Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-05
- Volume
- 146
- Issue
- 10
- Pages
- 3444-3451
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1515615230
- Cited by
- 1,865
- References
- 0
- FWCI
- 36.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.